Levosulpiride + Rabeprazole in pharma franchise in Jharkhand

Levosulpiride + Rabeprazole in PCD pharma franchise in Gangtok

Levosulpiride + Rabeprazole in top pharma company in Itanagar

Levosulpiride + Rabeprazole in pcd pharma supplier in Bharuch

Levosulpiride + Rabeprazole in phama franchise company in India
Levosulpiride + Rabeprazole in phama distributor in Tirupati

Home/Products /levosulpiride-75mg-rabeprazole-20mg-capsules

Ribziff L Capsule

Composition : Levosulpiride (75mg) + Rabeprazole (20mg)

Dosage Form : Capsule

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹206/-

Ribziff L Capsule is a combination medicine designed to address gastroesophageal reflux disease (GERD), acid reflux, and functional dyspepsia. The formulation combines Levosulpiride, a prokinetic agent that enhances gastrointestinal motility, with Rabeprazole, a proton pump inhibitor (PPI) that reduces stomach acid production. Together, they provide comprehensive relief by alleviating symptoms such as heartburn, bloating, and nausea while promoting faster gastric emptying.

Levosulpiride works by modulating dopamine receptors in the gut, improving gastrointestinal movement and reducing acid regurgitation. Rabeprazole inhibits the final step in gastric acid secretion, creating a long-lasting reduction in stomach acidity and fostering the healing of ulcers and inflamed esophageal linings. This synergistic action makes Ribziff L a reliable solution for patients suffering from GERD and related conditions.

The capsule form offers convenience and precise dosing, ensuring optimal therapeutic benefits. Ribziff L is best taken before meals to enhance its efficacy.

Read More

About the Product

Ribziff L Capsule is a combination medicine designed to address gastroesophageal reflux disease (GERD), acid reflux, and functional dyspepsia. The formulation combines Levosulpiride, a prokinetic agent that enhances gastrointestinal motility, with Rabeprazole, a proton pump inhibitor (PPI) that reduces stomach acid production. Together, they provide comprehensive relief by alleviating symptoms such as heartburn, bloating, and nausea while promoting faster gastric emptying.

Levosulpiride works by modulating dopamine receptors in the gut, improving gastrointestinal movement and reducing acid regurgitation. Rabeprazole inhibits the final step in gastric acid secretion, creating a long-lasting reduction in stomach acidity and fostering the healing of ulcers and inflamed esophageal linings. This synergistic action makes Ribziff L a reliable solution for patients suffering from GERD and related conditions.

The capsule form offers convenience and precise dosing, ensuring optimal therapeutic benefits. Ribziff L is best taken before meals to enhance its efficacy.

Common side effects include dizziness, headache, nausea, diarrhea, or constipation. Rarely, it may cause allergic reactions, fatigue, or changes in liver enzymes.

Indicated for gastroesophageal reflux disease (GERD), functional dyspepsia, and related acid reflux conditions.

Use only as prescribed by a healthcare professional. Avoid in cases of known allergies to PPIs or prokinetic agents. Do not discontinue abruptly without consulting your doctor.

Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation